IXAKA Trademark

Trademark Overview


On Wednesday, March 3, 2021, a trademark application was filed for IXAKA with the United States Patent and Trademark Office. The USPTO has given the IXAKA trademark a serial number of 90557596. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2024. This trademark is owned by Ixaka Limited. The IXAKA trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Production of cell lines for use in the manufacture of biopharmaceuticals; Protein fabrication, production, and manufacture for others; Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of biopharmaceuticals by pharmaceutical compounders

Chemical, analytical and diagnostic reagents for in vivo use for medical purposes; Pharmaceutical preparations for use in the prevention and treatment of cardiovascular diseases, cancer and genetic disorders; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders

Chemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific or research use

Drug delivery devices sold empty, namely, syringes, bags, infusion and injection sets; structural parts, fittings and accessories for all the aforesaid goods

Scientific, medical and industrial research and development services in the field of cardiovascular diseases, cancer, genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; clinical research in the field of cardiovascular diseases, cancer and genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; laboratory research in the field of cardiovascular diseases, cancer and genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; research and development of new drugs and clinical products; materials analyzing; chemical analysis; scientific laboratory services; laboratory testing services for scientific research purposes; medical laboratory services; information and advisory services relating to the foregoing, including such se...
ixaka

General Information


Serial Number90557596
Word MarkIXAKA
Filing DateWednesday, March 3, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements


Goods and ServicesProduction of cell lines for use in the manufacture of biopharmaceuticals; Protein fabrication, production, and manufacture for others; Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of biopharmaceuticals by pharmaceutical compounders
Description of MarkThe mark consists of the stylized lettering "IXAKA", all depicted in dark blue with the exception of the top half of the letter "X", which is depicted in light blue; a light blue dot is positioned above the letter "X" to create a schematic human form; all of the aforementioned being shown on a white background, with the color white being used to designate transparent portions of the drawing to illustrate a contrasting background.
Goods and ServicesChemical, analytical and diagnostic reagents for in vivo use for medical purposes; Pharmaceutical preparations for use in the prevention and treatment of cardiovascular diseases, cancer and genetic disorders; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders
Indication of Colors claimedThe color(s) dark blue and light blue is/are claimed as a feature of the mark.
Goods and ServicesChemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific or research use
Goods and ServicesDrug delivery devices sold empty, namely, syringes, bags, infusion and injection sets; structural parts, fittings and accessories for all the aforesaid goods
Goods and ServicesScientific, medical and industrial research and development services in the field of cardiovascular diseases, cancer, genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; clinical research in the field of cardiovascular diseases, cancer and genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; laboratory research in the field of cardiovascular diseases, cancer and genetic disorders, ophthalmic diseases and conditions, inflammation and inflammatory diseases and disorders and metabolic diseases and disorders; research and development of new drugs and clinical products; materials analyzing; chemical analysis; scientific laboratory services; laboratory testing services for scientific research purposes; medical laboratory services; information and advisory services relating to the foregoing, including such services provided on-line from a computer network or the Internet; Research and development services for pharmaceuticals and for the treatment of diseases and injuries; Genetic engineering services for scientific research purposes; Genetic research being scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals and gene therapy; medical and scientific research, namely, conducting clinical trials for others; Research and development of pharmaceutical preparations

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIxaka Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon SW1X0BD
GB

Party NameIxaka Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon SW1X0BD
GB

Trademark Events


Event DateEvent Description
Monday, March 4, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 2, 2023SOU EXTENSION 2 FILED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU EXTENSION 1 GRANTED
Monday, December 12, 2022SOU EXTENSION 1 FILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, March 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 26, 2022ASSIGNED TO LIE
Wednesday, March 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 26, 2021NON-FINAL ACTION E-MAILED
Sunday, September 26, 2021NON-FINAL ACTION WRITTEN
Saturday, September 25, 2021ASSIGNED TO EXAMINER
Thursday, June 3, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, June 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 6, 2021NEW APPLICATION ENTERED